Newark, DE, United States of America

Hai Fen Ye

This inventor holds 19 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Incyte Corporation. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hai Fen Ye. Retrieved from https://idiyas.com/inventor/hai-fen-ye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 94.7

 

 

Average Co-Inventor Count = 6.5

ph-index = 8

Forward Citations = 140(Granted Patents)


Company Filing History:


Years Active: 2009-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pyrazolopyridine
Bicyclic Heterocycles
FGFR Inhibitors
CDK12 Inhibitors
Isoindolinone
Pyrrolopyridinone
Purinone Derivatives
HM74A Agonists
Cyanoindazole
Bicyclic Amines
Pyrimidine Compounds
Pharmaceuticals
19 patents (USPTO):Explore Patents

Title: Innovations by Hai Fen Ye – A Leader in Pharmaceutical Patents

Introduction

Hai Fen Ye, an accomplished inventor based in Newark, DE, has made significant strides in the pharmaceutical industry with a total of 18 patents to his name. His innovative work primarily centers around compounds that target critical pathways in cancer biology and other diseases.

Latest Patents

Among his most recent patents are two noteworthy inventions. The first, titled "Pyrazolopyridine Compounds and Uses Thereof," discloses various compounds designed to inhibit HPK1 activity. These compounds have promising applications in treating, preventing, or ameliorating diseases linked to HPK1 activity, particularly cancer. The second patent, "Bicyclic Heterocycles as FGFR Inhibitors," relates to new bicyclic heterocycles that serve as inhibitors of the FGFR3 enzyme. This invention holds potential for treating diseases associated with FGFR3, including certain cancers.

Career Highlights

Hai Fen Ye currently works at Incyte Corporation, a company known for its cutting-edge research and development in the field of oncology and other therapeutic areas. His contributions to the field of pharmacology through innovative compounds have positioned him among the leading inventors in this domain.

Collaborations

At Incyte Corporation, Hai Fen collaborates with notable colleagues such as Oleg Vechorkin and Wenqing Yao. Together, they work on developing groundbreaking solutions in the pharmaceutical landscape, pushing the boundaries of what's possible in disease treatment.

Conclusion

With 18 patents reflecting his dedication to advancing healthcare, Hai Fen Ye continues to be a pivotal figure in pharmaceutical innovation. His discoveries not only contribute to scientific knowledge but also inspire future developments in treating life-altering diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…